APO Research

APO RESEARCH · REPORT

Plasma Fractionation Technology

Selected research

Market Analysis & Forecast

Global Plasma Fractionation Technology Market Analysis and Forecast 2026-2032

Market perspective

The global Plasma Fractionation Technology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plasma Fractionation Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plasma Fractionation Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plasma Fractionation Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plasma Fractionation Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plasma Fractionation Technology include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plasma Fractionation Technology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasma Fractionation Technology, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasma Fractionation Technology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma Fractionation Technology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma Fractionation Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasma Fractionation Technology revenue, projected growth trends, production technology, application and end-user industry.

Plasma Fractionation Technology Segment by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Tiantan Bio

Shuanglin Bio

Boya Bio

Yuanda Shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Plasma Fractionation Technology Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Other

Plasma Fractionation Technology Segment by Application

Hospital

Retail Pharmacy

Other

Plasma Fractionation Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plasma Fractionation Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plasma Fractionation Technology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Fractionation Technology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasma Fractionation Technology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune Globulin Major Player Table 3. Coagulation Factor Major Player Table 4. Albumin Major Player Table 5. Other Major Player Table 6. Global Plasma Fractionation Technology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Retail Pharmacy Major Player Table 9. Other Major Player Table 10. Plasma Fractionation Technology Industry Trends Table 11. Plasma Fractionation Technology Industry Drivers Table 12. Plasma Fractionation Technology Industry Opportunities and Challenges Table 13. Plasma Fractionation Technology Industry Restraints Table 14. Global Plasma Fractionation Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Plasma Fractionation Technology Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Plasma Fractionation Technology Market Share by Region (2021-2026) Table 17. Global Plasma Fractionation Technology Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Plasma Fractionation Technology Market Share by Region (2027-2032) Table 19. Global Plasma Fractionation Technology Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Plasma Fractionation Technology Revenue Market Share by Players (2021-2026) Table 21. Global Plasma Fractionation Technology Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Plasma Fractionation Technology Key Players Headquarters & Area Served Table 23. Global Plasma Fractionation Technology Players, Product Type & Application Table 24. Global Plasma Fractionation Technology Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Plasma Fractionation Technology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Plasma Fractionation Technology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Plasma Fractionation Technology Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Plasma Fractionation Technology Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Plasma Fractionation Technology Revenue Market Share by Type (2021-2026) Table 31. Global Plasma Fractionation Technology Revenue Market Share by Type (2027-2032) Table 32. Global Plasma Fractionation Technology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Plasma Fractionation Technology Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Plasma Fractionation Technology Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Plasma Fractionation Technology Revenue Market Share by Application (2021-2026) Table 36. Global Plasma Fractionation Technology Revenue Market Share by Application (2027-2032) Table 37. Takeda Company Information Table 38. Takeda Business Overview Table 39. Takeda Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Takeda Plasma Fractionation Technology Product Portfolio Table 41. Takeda Recent Development Table 42. CSL Company Information Table 43. CSL Business Overview Table 44. CSL Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. CSL Plasma Fractionation Technology Product Portfolio Table 46. CSL Recent Development Table 47. Grifols Company Information Table 48. Grifols Business Overview Table 49. Grifols Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Grifols Plasma Fractionation Technology Product Portfolio Table 51. Grifols Recent Development Table 52. Octapharma Company Information Table 53. Octapharma Business Overview Table 54. Octapharma Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Octapharma Plasma Fractionation Technology Product Portfolio Table 56. Octapharma Recent Development Table 57. Kedrion Company Information Table 58. Kedrion Business Overview Table 59. Kedrion Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Kedrion Plasma Fractionation Technology Product Portfolio Table 61. Kedrion Recent Development Table 62. LFB Group Company Information Table 63. LFB Group Business Overview Table 64. LFB Group Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. LFB Group Plasma Fractionation Technology Product Portfolio Table 66. LFB Group Recent Development Table 67. Biotest Company Information Table 68. Biotest Business Overview Table 69. Biotest Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Biotest Plasma Fractionation Technology Product Portfolio Table 71. Biotest Recent Development Table 72. BPL Company Information Table 73. BPL Business Overview Table 74. BPL Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. BPL Plasma Fractionation Technology Product Portfolio Table 76. BPL Recent Development Table 77. RAAS Company Information Table 78. RAAS Business Overview Table 79. RAAS Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. RAAS Plasma Fractionation Technology Product Portfolio Table 81. RAAS Recent Development Table 82. CBPO Company Information Table 83. CBPO Business Overview Table 84. CBPO Plasma Fractionation Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. CBPO Plasma Fractionation Technology Product Portfolio Table 86. CBPO Recent Development Table 87. Hualan Bio Company Information Table 88. Hualan Bio Business Overview Table 89. Hualan Bio Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Hualan Bio Plasma Fractionation Technology Product Portfolio Table 91. Hualan Bio Recent Development Table 92. Tiantan Bio Company Information Table 93. Tiantan Bio Business Overview Table 94. Tiantan Bio Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Tiantan Bio Plasma Fractionation Technology Product Portfolio Table 96. Tiantan Bio Recent Development Table 97. Shuanglin Bio Company Information Table 98. Shuanglin Bio Business Overview Table 99. Shuanglin Bio Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Shuanglin Bio Plasma Fractionation Technology Product Portfolio Table 101. Shuanglin Bio Recent Development Table 102. Boya Bio Company Information Table 103. Boya Bio Business Overview Table 104. Boya Bio Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Boya Bio Plasma Fractionation Technology Product Portfolio Table 106. Boya Bio Recent Development Table 107. Yuanda Shuyang Company Information Table 108. Yuanda Shuyang Business Overview Table 109. Yuanda Shuyang Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Yuanda Shuyang Plasma Fractionation Technology Product Portfolio Table 111. Yuanda Shuyang Recent Development Table 112. Weiguang Bio Company Information Table 113. Weiguang Bio Business Overview Table 114. Weiguang Bio Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Weiguang Bio Plasma Fractionation Technology Product Portfolio Table 116. Weiguang Bio Recent Development Table 117. Nanyue Bio Company Information Table 118. Nanyue Bio Business Overview Table 119. Nanyue Bio Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Nanyue Bio Plasma Fractionation Technology Product Portfolio Table 121. Nanyue Bio Recent Development Table 122. KM Biologics Company Information Table 123. KM Biologics Business Overview Table 124. KM Biologics Plasma Fractionation Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. KM Biologics Plasma Fractionation Technology Product Portfolio Table 126. KM Biologics Recent Development Table 127. North America Plasma Fractionation Technology Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Plasma Fractionation Technology Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Plasma Fractionation Technology Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Plasma Fractionation Technology Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Plasma Fractionation Technology Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Plasma Fractionation Technology Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Plasma Fractionation Technology Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Plasma Fractionation Technology Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Plasma Fractionation Technology Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Plasma Fractionation Technology Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Plasma Fractionation Technology Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Plasma Fractionation Technology Revenue by Country (US$ Million) & (2027-2032) Table 141. China Plasma Fractionation Technology Revenue by Type (2021-2026) & (US$ Million) Table 142. China Plasma Fractionation Technology Revenue by Type (2027-2032) & (US$ Million) Table 143. China Plasma Fractionation Technology Revenue by Application (2021-2026) & (US$ Million) Table 144. China Plasma Fractionation Technology Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Plasma Fractionation Technology Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Plasma Fractionation Technology Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Plasma Fractionation Technology Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Plasma Fractionation Technology Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Plasma Fractionation Technology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Plasma Fractionation Technology Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Plasma Fractionation Technology Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Plasma Fractionation Technology Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Plasma Fractionation Technology Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Plasma Fractionation Technology Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Plasma Fractionation Technology Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Plasma Fractionation Technology Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Plasma Fractionation Technology Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Plasma Fractionation Technology Image Figure 2. Global Plasma Fractionation Technology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Fractionation Technology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune Globulin Image Figure 5. Coagulation Factor Image Figure 6. Albumin Image Figure 7. Other Image Figure 8. Global Plasma Fractionation Technology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Plasma Fractionation Technology Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Plasma Fractionation Technology Market Size (US$ Million) & (2021-2032) Figure 14. Global Plasma Fractionation Technology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Plasma Fractionation Technology Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Plasma Fractionation Technology Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Plasma Fractionation Technology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Plasma Fractionation Technology Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Plasma Fractionation Technology Revenue Market Share by Type (2021-2032) Figure 21. Global Plasma Fractionation Technology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Plasma Fractionation Technology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Plasma Fractionation Technology Revenue Market Share by Application (2021-2032) Figure 24. North America Plasma Fractionation Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Plasma Fractionation Technology Revenue Share by Type (2021-2032) Figure 26. North America Plasma Fractionation Technology Revenue Share by Application (2021-2032) Figure 27. North America Plasma Fractionation Technology Revenue Share by Country (2021-2032) Figure 28. United States Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Plasma Fractionation Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Plasma Fractionation Technology Revenue Share by Type (2021-2032) Figure 33. Europe Plasma Fractionation Technology Revenue Share by Application (2021-2032) Figure 34. Europe Plasma Fractionation Technology Revenue Share by Country (2021-2032) Figure 35. Germany Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Plasma Fractionation Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Plasma Fractionation Technology Revenue Share by Type (2021-2032) Figure 45. China Plasma Fractionation Technology Revenue Share by Application (2021-2032) Figure 46. Asia Plasma Fractionation Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Plasma Fractionation Technology Revenue Share by Type (2021-2032) Figure 48. Asia Plasma Fractionation Technology Revenue Share by Application (2021-2032) Figure 49. Asia Plasma Fractionation Technology Revenue Share by Region (2021-2032) Figure 50. Japan Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Plasma Fractionation Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Plasma Fractionation Technology Revenue Share by Type (2021-2032) Figure 58. SAMEA Plasma Fractionation Technology Revenue Share by Application (2021-2032) Figure 59. SAMEA Plasma Fractionation Technology Revenue Share by Country (2021-2032) Figure 60. Brazil Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Plasma Fractionation Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasma Fractionation Technology Market by Type
  3. 1.2.1 Global Plasma Fractionation Technology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune Globulin
  5. 1.2.3 Coagulation Factor
  6. 1.2.4 Albumin
  7. 1.2.5 Other
  8. 1.3 Plasma Fractionation Technology Market by Application
  9. 1.3.1 Global Plasma Fractionation Technology Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Plasma Fractionation Technology Market Dynamics
  1. 2.1 Plasma Fractionation Technology Industry Trends
  2. 2.2 Plasma Fractionation Technology Industry Drivers
  3. 2.3 Plasma Fractionation Technology Industry Opportunities and Challenges
  4. 2.4 Plasma Fractionation Technology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plasma Fractionation Technology Market Perspective (2021-2032)
  2. 3.2 Global Plasma Fractionation Technology Growth Trends by Region
  3. 3.2.1 Global Plasma Fractionation Technology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasma Fractionation Technology Market Size by Region (2021-2026)
  5. 3.2.3 Global Plasma Fractionation Technology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plasma Fractionation Technology Revenue by Players
  2. 4.1.1 Global Plasma Fractionation Technology Revenue by Players (2021-2026)
  3. 4.1.2 Global Plasma Fractionation Technology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plasma Fractionation Technology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasma Fractionation Technology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plasma Fractionation Technology Key Players Headquarters & Area Served
  7. 4.4 Global Plasma Fractionation Technology Players, Product Type & Application
  8. 4.5 Global Plasma Fractionation Technology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plasma Fractionation Technology Market CR5 and HHI
  11. 4.6.3 2025 Plasma Fractionation Technology Tier 1, Tier 2, and Tier 3
5 Plasma Fractionation Technology Market Size by Type
  1. 5.1 Global Plasma Fractionation Technology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plasma Fractionation Technology Revenue by Type (2021-2032)
  3. 5.3 Global Plasma Fractionation Technology Revenue Market Share by Type (2021-2032)
6 Plasma Fractionation Technology Market Size by Application
  1. 6.1 Global Plasma Fractionation Technology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plasma Fractionation Technology Revenue by Application (2021-2032)
  3. 6.3 Global Plasma Fractionation Technology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Plasma Fractionation Technology Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 CSL
  8. 7.2.1 CSL Company Information
  9. 7.2.2 CSL Business Overview
  10. 7.2.3 CSL Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CSL Plasma Fractionation Technology Product Portfolio
  12. 7.2.5 CSL Recent Developments
  13. 7.3 Grifols
  14. 7.3.1 Grifols Company Information
  15. 7.3.2 Grifols Business Overview
  16. 7.3.3 Grifols Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Grifols Plasma Fractionation Technology Product Portfolio
  18. 7.3.5 Grifols Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Plasma Fractionation Technology Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 Kedrion
  26. 7.5.1 Kedrion Company Information
  27. 7.5.2 Kedrion Business Overview
  28. 7.5.3 Kedrion Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Kedrion Plasma Fractionation Technology Product Portfolio
  30. 7.5.5 Kedrion Recent Developments
  31. 7.6 LFB Group
  32. 7.6.1 LFB Group Company Information
  33. 7.6.2 LFB Group Business Overview
  34. 7.6.3 LFB Group Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LFB Group Plasma Fractionation Technology Product Portfolio
  36. 7.6.5 LFB Group Recent Developments
  37. 7.7 Biotest
  38. 7.7.1 Biotest Company Information
  39. 7.7.2 Biotest Business Overview
  40. 7.7.3 Biotest Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Biotest Plasma Fractionation Technology Product Portfolio
  42. 7.7.5 Biotest Recent Developments
  43. 7.8 BPL
  44. 7.8.1 BPL Company Information
  45. 7.8.2 BPL Business Overview
  46. 7.8.3 BPL Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BPL Plasma Fractionation Technology Product Portfolio
  48. 7.8.5 BPL Recent Developments
  49. 7.9 RAAS
  50. 7.9.1 RAAS Company Information
  51. 7.9.2 RAAS Business Overview
  52. 7.9.3 RAAS Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 RAAS Plasma Fractionation Technology Product Portfolio
  54. 7.9.5 RAAS Recent Developments
  55. 7.10 CBPO
  56. 7.10.1 CBPO Company Information
  57. 7.10.2 CBPO Business Overview
  58. 7.10.3 CBPO Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CBPO Plasma Fractionation Technology Product Portfolio
  60. 7.10.5 CBPO Recent Developments
  61. 7.11 Hualan Bio
  62. 7.11.1 Hualan Bio Company Information
  63. 7.11.2 Hualan Bio Business Overview
  64. 7.11.3 Hualan Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Hualan Bio Plasma Fractionation Technology Product Portfolio
  66. 7.11.5 Hualan Bio Recent Developments
  67. 7.12 Tiantan Bio
  68. 7.12.1 Tiantan Bio Company Information
  69. 7.12.2 Tiantan Bio Business Overview
  70. 7.12.3 Tiantan Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Tiantan Bio Plasma Fractionation Technology Product Portfolio
  72. 7.12.5 Tiantan Bio Recent Developments
  73. 7.13 Shuanglin Bio
  74. 7.13.1 Shuanglin Bio Company Information
  75. 7.13.2 Shuanglin Bio Business Overview
  76. 7.13.3 Shuanglin Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Shuanglin Bio Plasma Fractionation Technology Product Portfolio
  78. 7.13.5 Shuanglin Bio Recent Developments
  79. 7.14 Boya Bio
  80. 7.14.1 Boya Bio Company Information
  81. 7.14.2 Boya Bio Business Overview
  82. 7.14.3 Boya Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Boya Bio Plasma Fractionation Technology Product Portfolio
  84. 7.14.5 Boya Bio Recent Developments
  85. 7.15 Yuanda Shuyang
  86. 7.15.1 Yuanda Shuyang Company Information
  87. 7.15.2 Yuanda Shuyang Business Overview
  88. 7.15.3 Yuanda Shuyang Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Yuanda Shuyang Plasma Fractionation Technology Product Portfolio
  90. 7.15.5 Yuanda Shuyang Recent Developments
  91. 7.16 Weiguang Bio
  92. 7.16.1 Weiguang Bio Company Information
  93. 7.16.2 Weiguang Bio Business Overview
  94. 7.16.3 Weiguang Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Weiguang Bio Plasma Fractionation Technology Product Portfolio
  96. 7.16.5 Weiguang Bio Recent Developments
  97. 7.17 Nanyue Bio
  98. 7.17.1 Nanyue Bio Company Information
  99. 7.17.2 Nanyue Bio Business Overview
  100. 7.17.3 Nanyue Bio Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Nanyue Bio Plasma Fractionation Technology Product Portfolio
  102. 7.17.5 Nanyue Bio Recent Developments
  103. 7.18 KM Biologics
  104. 7.18.1 KM Biologics Company Information
  105. 7.18.2 KM Biologics Business Overview
  106. 7.18.3 KM Biologics Plasma Fractionation Technology Revenue and Gross Margin (2021-2026)
  107. 7.18.4 KM Biologics Plasma Fractionation Technology Product Portfolio
  108. 7.18.5 KM Biologics Recent Developments
8 North America
  1. 8.1 North America Plasma Fractionation Technology Revenue (2021-2032)
  2. 8.2 North America Plasma Fractionation Technology Revenue by Type (2021-2032)
  3. 8.2.1 North America Plasma Fractionation Technology Revenue by Type (2021-2026)
  4. 8.2.2 North America Plasma Fractionation Technology Revenue by Type (2027-2032)
  5. 8.3 North America Plasma Fractionation Technology Revenue Share by Type (2021-2032)
  6. 8.4 North America Plasma Fractionation Technology Revenue by Application (2021-2032)
  7. 8.4.1 North America Plasma Fractionation Technology Revenue by Application (2021-2026)
  8. 8.4.2 North America Plasma Fractionation Technology Revenue by Application (2027-2032)
  9. 8.5 North America Plasma Fractionation Technology Revenue Share by Application (2021-2032)
  10. 8.6 North America Plasma Fractionation Technology Revenue by Country
  11. 8.6.1 North America Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plasma Fractionation Technology Revenue by Country (2021-2026)
  13. 8.6.3 North America Plasma Fractionation Technology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Plasma Fractionation Technology Revenue (2021-2032)
  2. 9.2 Europe Plasma Fractionation Technology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plasma Fractionation Technology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plasma Fractionation Technology Revenue by Type (2027-2032)
  5. 9.3 Europe Plasma Fractionation Technology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plasma Fractionation Technology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plasma Fractionation Technology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plasma Fractionation Technology Revenue by Application (2027-2032)
  9. 9.5 Europe Plasma Fractionation Technology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plasma Fractionation Technology Revenue by Country
  11. 9.6.1 Europe Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plasma Fractionation Technology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plasma Fractionation Technology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Plasma Fractionation Technology Revenue (2021-2032)
  2. 10.2 China Plasma Fractionation Technology Revenue by Type (2021-2032)
  3. 10.2.1 China Plasma Fractionation Technology Revenue by Type (2021-2026)
  4. 10.2.2 China Plasma Fractionation Technology Revenue by Type (2027-2032)
  5. 10.3 China Plasma Fractionation Technology Revenue Share by Type (2021-2032)
  6. 10.4 China Plasma Fractionation Technology Revenue by Application (2021-2032)
  7. 10.4.1 China Plasma Fractionation Technology Revenue by Application (2021-2026)
  8. 10.4.2 China Plasma Fractionation Technology Revenue by Application (2027-2032)
  9. 10.5 China Plasma Fractionation Technology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasma Fractionation Technology Revenue (2021-2032)
  2. 11.2 Asia Plasma Fractionation Technology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plasma Fractionation Technology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plasma Fractionation Technology Revenue by Type (2027-2032)
  5. 11.3 Asia Plasma Fractionation Technology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plasma Fractionation Technology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plasma Fractionation Technology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plasma Fractionation Technology Revenue by Application (2027-2032)
  9. 11.5 Asia Plasma Fractionation Technology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plasma Fractionation Technology Revenue by Country
  11. 11.6.1 Asia Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plasma Fractionation Technology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plasma Fractionation Technology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasma Fractionation Technology Revenue (2021-2032)
  2. 12.2 SAMEA Plasma Fractionation Technology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plasma Fractionation Technology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plasma Fractionation Technology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plasma Fractionation Technology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plasma Fractionation Technology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plasma Fractionation Technology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plasma Fractionation Technology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plasma Fractionation Technology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plasma Fractionation Technology Revenue by Country
  11. 12.6.1 SAMEA Plasma Fractionation Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plasma Fractionation Technology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plasma Fractionation Technology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research